{
    "type": "relationship",
    "id": "relationship--364d9326-12af-4449-924c-8063f4b3aa41",
    "created_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
    "created": "2020-09-30T14:29:28.434Z",
    "modified": "2020-09-30T14:29:28.434Z",
    "relationship_type": "uses",
    "description": "(Citation: NCSC APT29 July 2020)(Citation: CISA SoreFang July 2016)",
    "source_ref": "intrusion-set--899ce53f-13a0-479b-a0e4-67d46e241542",
    "target_ref": "malware--e33e4603-afab-402d-b2a1-248d435b5fe0",
    "external_references": [
        {
            "source_name": "NCSC APT29 July 2020",
            "description": "National Cyber Security Centre. (2020, July 16). Advisory: APT29 targets COVID-19 vaccine development. Retrieved September 29, 2020.",
            "url": "https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development-V1-1.pdf"
        },
        {
            "source_name": "CISA SoreFang July 2016",
            "description": "CISA. (2020, July 16). MAR-10296782-1.v1 â€“ SOREFANG. Retrieved September 29, 2020.",
            "url": "https://us-cert.cisa.gov/ncas/analysis-reports/ar20-198a"
        }
    ],
    "object_marking_refs": [
        "marking-definition--fa42a846-8d90-4e51-bc29-71d5b4802168"
    ],
    "x_mitre_modified_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
    "x_mitre_version": "1.0"
}